- 4-Week # shares bought: 38,600
- 4-Week # shares sold: 6,037
- 12-Week # shares bought: 38,600
- 12-Week # shares sold: 6,037
- 24-Week # shares bought: 38,600
- 24-Week # shares sold: 11,089
Where some see danger and upheaval, investors see opportunity. And the harrowing Zika virus is no different. Investors are jumping into stocks focused on detecting or wiping out the virus.
Medical technology companies are hot, says Rich Newitter, managing director at Leerink.